Acta Scientific Pharmacology

Short Communication Volume 1 Issue 5

Diagnostic Testing for COVID-19

Marwa EL-Sayed*

Department of Biopharmacy/Clinical Pharmacy, Faculty of Pharmacy, Tanta University, Egypt

*Corresponding Author: Marwa EL-Sayed, Department of Biopharmacy/Clinical Pharmacy, Faculty of Pharmacy, Tanta University, Egypt

Received: March 25, 2020; Published: April 16, 2020

Reprints View PDF Related Articles

×

Diagnostic tests for detecting infection with corona virus are considered useful in defining patients who experienced the clinical symptoms for COVID-19. More than 20 molecular tests are now available for detecting the genetic material of the virus. The other side for using diagnostic tests is to enable health measures like quarantine to be achieved.

×

Citation

Citation: Marwa EL-Sayed. “Diagnostic Testing for COVID-19". Acta Scientific Pharmacology 1.5 (2020): 03.




Metrics

Acceptance rate35%
Acceptance to publication20-30 days
Impact Factor1.183

Indexed In




News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is December 25, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"

Contact US





Creative Commons License Open Access by Acta Scientific is licensed under a Creative Commons Attribution 4.0 International License
Based on a work at https://actascientific.com

ff

Acta-Publications

ff

© 2021 Acta Scientific, All rights reserved.